IL6 and lymphopenia: COVID-19 patients with weaker innate immunity, as manifested by lower HLA-II expression level [1], are more likely to show severe symptoms (~20%), including lymphopenia and cytokine release syndrome [2], otherwise known as “cytokine storm”, accompanied by elevation of the proinflammatory cytokine IL-6.